Literature DB >> 22496151

Emergence of T cells that recognize nonpolymorphic antigens during graft-versus- host disease.

Hemalatha Rangarajan1, Maryam Yassai, Hariharan Subramanian, Richard Komorowski, Megan Whitaker, Jack Gorski, William R Drobyski.   

Abstract

Chronic GVHD is a major cause of morbidity and mortality in allogeneic stem cell transplantation recipients and typically develops from antecedent acute GVHD. In contrast to acute GVHD, chronic GVHD has much broader tissue involvement and clinical manifestations that bear striking similarity to what is observed in autoimmune diseases. How autoimmunity arises out of alloimmunity has been a longstanding unresolved issue. To address this question, in the present study, we performed a comprehensive analysis of the clonotypic T-cell response using complementary murine models that simulate what occurs during the transition from acute to chronic GVHD. These studies revealed repertoire skewing and the presence of high-frequency clonotypes that had undergone significant in vivo expansion, indicating that GVHD-associated autoimmunity was characterized by antigen-driven expansion of a limited number of T-cell clones. Furthermore, we observed that T cells with identical TCRβ CDR3 nucleotide sequences were capable of recognizing donor and host antigens, providing evidence that the loss of self-tolerance during acute GVHD leads to the emergence of self-reactive donor T cells that are capable of recognizing nonpolymorphic tissue or commensally derived antigens. These data provide a mechanistic framework for how autoimmunity develops within the context of preexisting GVHD and provide additional insight into the pathophysiology of chronic GVHD.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22496151      PMCID: PMC3383195          DOI: 10.1182/blood-2012-01-401596

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  55 in total

1.  Size estimate of the alpha beta TCR repertoire of naive mouse splenocytes.

Authors:  A Casrouge; E Beaudoing; S Dalle; C Pannetier; J Kanellopoulos; P Kourilsky
Journal:  J Immunol       Date:  2000-06-01       Impact factor: 5.422

2.  Characterization of the T-cell repertoire in autologous graft-versus-host disease (GVHD): evidence for the involvement of antigen-driven T-cell response in the development of autologous GVHD.

Authors:  Y Miura; C J Thoburn; E C Bright; M Sommer; S Lefell; M Ueda; S Nakao; A D Hess
Journal:  Blood       Date:  2001-08-01       Impact factor: 22.113

3.  Disruption of a new forkhead/winged-helix protein, scurfin, results in the fatal lymphoproliferative disorder of the scurfy mouse.

Authors:  M E Brunkow; E W Jeffery; K A Hjerrild; B Paeper; L B Clark; S A Yasayko; J E Wilkinson; D Galas; S F Ziegler; F Ramsdell
Journal:  Nat Genet       Date:  2001-01       Impact factor: 38.330

4.  The murine mutation scurfy (sf) results in an antigen-dependent lymphoproliferative disease with altered T cell sensitivity.

Authors:  J L Zahorsky-Reeves; J E Wilkinson
Journal:  Eur J Immunol       Date:  2001-01       Impact factor: 5.532

5.  Systemic activation and antigen-driven oligoclonal expansion of T cells in a mouse model of colitis.

Authors:  J L Matsuda; L Gapin; B C Sydora; F Byrne; S Binder; M Kronenberg; R Aranda
Journal:  J Immunol       Date:  2000-03-01       Impact factor: 5.422

6.  Colitis induced by enteric bacterial antigen-specific CD4+ T cells requires CD40-CD40 ligand interactions for a sustained increase in mucosal IL-12.

Authors:  Y Cong; C T Weaver; A Lazenby; C O Elson
Journal:  J Immunol       Date:  2000-08-15       Impact factor: 5.422

Review 7.  The immunology of mucosal models of inflammation.

Authors:  Warren Strober; Ivan J Fuss; Richard S Blumberg
Journal:  Annu Rev Immunol       Date:  2001-10-04       Impact factor: 28.527

8.  A molecular marker for thymocyte-positive selection: selection of CD4 single-positive thymocytes with shorter TCRB CDR3 during T cell development.

Authors:  Maryam Yassai; Kristin Ammon; Joan Goverman; Phillipa Marrack; Yuri Naumov; Jack Gorski
Journal:  J Immunol       Date:  2002-04-15       Impact factor: 5.422

9.  Rapid establishment of dendritic cell chimerism in allogeneic hematopoietic cell transplant recipients.

Authors:  Susanne Auffermann-Gretzinger; Izidore S Lossos; Tamara A Vayntrub; Wendy Leong; F Carl Grumet; Karl G Blume; Keith E Stockerl-Goldstein; Ronald Levy; Judith A Shizuru
Journal:  Blood       Date:  2002-02-15       Impact factor: 22.113

10.  Ulcerative colitis-like disease in mice with a disrupted interleukin-2 gene.

Authors:  B Sadlack; H Merz; H Schorle; A Schimpl; A C Feller; I Horak
Journal:  Cell       Date:  1993-10-22       Impact factor: 41.582

View more
  11 in total

1.  Proinflammatory Dual Receptor T Cells in Chronic Graft-versus-Host Disease.

Authors:  Amritha Balakrishnan; Nicholas Gloude; Roman Sasik; Edward D Ball; Gerald P Morris
Journal:  Biol Blood Marrow Transplant       Date:  2017-07-24       Impact factor: 5.742

2.  Administration of anti-CD20 mAb is highly effective in preventing but ineffective in treating chronic graft-versus-host disease while preserving strong graft-versus-leukemia effects.

Authors:  Heather F Johnston; Yajing Xu; Jeremy J Racine; Kaniel Cassady; Xiong Ni; Tao Wu; Andrew Chan; Stephen Forman; Defu Zeng
Journal:  Biol Blood Marrow Transplant       Date:  2014-05-04       Impact factor: 5.742

3.  Recruitment of Donor T Cells to the Eyes During Ocular GVHD in Recipients of MHC-Matched Allogeneic Hematopoietic Stem Cell Transplants.

Authors:  Samantha Herretes; Duncan B Ross; Stephanie Duffort; Henry Barreras; Tan Yaohong; Ali M Saeed; Juan C Murillo; Krishna V Komanduri; Robert B Levy; Victor L Perez
Journal:  Invest Ophthalmol Vis Sci       Date:  2015-04       Impact factor: 4.799

Review 4.  Toward a Better Understanding of the Atypical Features of Chronic Graft-Versus-Host Disease: A Report from the 2020 National Institutes of Health Consensus Project Task Force.

Authors:  Geoffrey D E Cuvelier; Michelle Schoettler; Nataliya P Buxbaum; Iago Pinal-Fernandez; Marc Schmalzing; Jörg H W Distler; Olaf Penack; Bianca D Santomasso; Robert Zeiser; Klemens Angstwurm; Kelli P A MacDonald; W Taylor Kimberly; Naomi Taylor; Ervina Bilic; Bernhard Banas; Maike Buettner-Herold; Namita Sinha; Hildegard T Greinix; Joseph Pidala; Kirk R Schultz; Kirsten M Williams; Yoshihiro Inamoto; Corey Cutler; Linda M Griffith; Stephanie J Lee; Stefanie Sarantopoulos; Steven Z Pavletic; Daniel Wolff
Journal:  Transplant Cell Ther       Date:  2022-05-31

5.  Thymic damage, impaired negative selection, and development of chronic graft-versus-host disease caused by donor CD4+ and CD8+ T cells.

Authors:  Tao Wu; James S Young; Heather Johnston; Xiong Ni; Ruishu Deng; Jeremy Racine; Miao Wang; Audrey Wang; Ivan Todorov; Jianmin Wang; Defu Zeng
Journal:  J Immunol       Date:  2013-05-24       Impact factor: 5.422

6.  Superior immune reconstitution using Treg-expanded donor cells versus PTCy treatment in preclinical HSCT models.

Authors:  Dietlinde Wolf; Cameron S Bader; Henry Barreras; Sabrina Copsel; Brent J Pfeiffer; Casey O Lightbourn; Norman H Altman; Krishna V Komanduri; Robert B Levy
Journal:  JCI Insight       Date:  2018-10-18

7.  Recipient-specific T-cell repertoire reconstitution in the gut following murine hematopoietic cell transplant.

Authors:  Pingping Zheng; John Tamaresis; Govindarajan Thangavelu; Liwen Xu; Xiaoqing You; Bruce R Blazar; Robert S Negrin; James L Zehnder; Bettina P Iliopoulou; Everett H Meyer
Journal:  Blood Adv       Date:  2020-09-08

Review 8.  The Biology of Chronic Graft-versus-Host Disease: A Task Force Report from the National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease.

Authors:  Kenneth R Cooke; Leo Luznik; Stefanie Sarantopoulos; Frances T Hakim; Madan Jagasia; Daniel H Fowler; Marcel R M van den Brink; John A Hansen; Robertson Parkman; David B Miklos; Paul J Martin; Sophie Paczesny; Georgia Vogelsang; Steven Pavletic; Jerome Ritz; Kirk R Schultz; Bruce R Blazar
Journal:  Biol Blood Marrow Transplant       Date:  2016-10-03       Impact factor: 5.742

Review 9.  The allure and peril of hematopoietic stem cell transplantation: overcoming immune challenges to improve success.

Authors:  Robert G Newman; Duncan B Ross; Henry Barreras; Samantha Herretes; Eckhard R Podack; Krishna V Komanduri; Victor L Perez; Robert B Levy
Journal:  Immunol Res       Date:  2013-12       Impact factor: 2.829

Review 10.  T Cell Receptor Profiling in Type 1 Diabetes.

Authors:  Laura M Jacobsen; Amanda Posgai; Howard R Seay; Michael J Haller; Todd M Brusko
Journal:  Curr Diab Rep       Date:  2017-10-11       Impact factor: 4.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.